‘Vive la Résistance!’ – the PI3K–Akt pathway can determine target sensitivity to regulatory T cell suppression
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 28 (4) , 154-160
- https://doi.org/10.1016/j.it.2007.02.003
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cellsLeukemia, 2006
- From Vanilla to 28 Flavors: Multiple Varieties of T Regulatory CellsImmunity, 2006
- TRAF6 is a T cell–intrinsic negative regulator required for the maintenance of immune homeostasisNature Medicine, 2006
- Cutting Edge: Deficiency in the E3 Ubiquitin Ligase Cbl-b Results in a Multifunctional Defect in T Cell TGF-β Sensitivity In Vitro and In VivoThe Journal of Immunology, 2006
- Autoimmune Diabetes Onset Results From Qualitative Rather Than Quantitative Age-Dependent Changes in Pathogenic T-CellsDiabetes, 2005
- MRL/Mp CD4+,CD25− T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: A novel defect of T cell regulation in systemic lupus erythematosusArthritis & Rheumatism, 2005
- T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cellsThe Journal of Experimental Medicine, 2005
- NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cellsThe Journal of Experimental Medicine, 2005
- Resistance to CD4+CD25+ Regulatory T Cells and TGF-β in Cbl-b−/− MiceThe Journal of Immunology, 2004
- Dynamics of Pathogenic and Suppressor T Cells in Autoimmune Diabetes DevelopmentThe Journal of Immunology, 2003